Shanghai Junshi Biosciences Co., Ltd.

Shanghai Junshi Biosciences Co., Ltd.verified

1877.HK

Price:

$23.5

Market Cap:

$32.55B

Shanghai Junshi Biosciences Co., Ltd., a biopharmaceutical company, engages in the discovery, development, and commercialization of various drugs in the therapeutic areas of oncology, metabolic, autoimmune, neurologic, and infectious diseases in the People's Republic of China. The company offers JS001, a recombinant humanized anti-PD-1 monoclonal antibody under the trade name of TUOYI for the indication of melanoma, mucosal melanoma, soft tissue sarcoma, nasopharyngeal carcinoma, urothelial carcinoma, non-small cell lung carcinoma, triple negative breast carcinoma, esophageal squamous cell carcinoma, and hepatocellular carcinoma. It is also developing UBP1211, a biosimilar of Humira for the ...[Read more]

Industry

Biotechnology

IPO Date

2018-12-24

Stock Exchange

HKSE

Ticker

1877.HK

The PE Ratio as of June 2025 (TTM) for Shanghai Junshi Biosciences Co., Ltd. (1877.HK) is -15.99

According to Shanghai Junshi Biosciences Co., Ltd.’s latest financial reports and current stock price. The company's current PE Ratio is -15.99. This represents a change of -34.57% compared to the average of -24.44 of the last 4 quarters.

Shanghai Junshi Biosciences Co., Ltd. (1877.HK) Historical PE Ratio (quarterly & annually)

How has 1877.HK PE Ratio performed in the past?

The mean historical PE Ratio of Shanghai Junshi Biosciences Co., Ltd. over the last ten years is -227.99. The current -15.99 PE Ratio has changed 601.34% with respect to the historical average. Over the past ten years (40 quarters), 1877.HK's PE Ratio was at its highest in in the June 2019 quarter at 352.88. The PE Ratio was at its lowest in in the June 2015 quarter at -1198.41.

Quarterly (TTM)
Annual

Average

-227.99

Median

-104.37

Minimum

-869.97

Maximum

-18.04

Shanghai Junshi Biosciences Co., Ltd. (1877.HK) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Shanghai Junshi Biosciences Co., Ltd. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 92.71%

Maximum Annual PE Ratio = -18.04

Minimum Annual Increase = -73.30%

Minimum Annual PE Ratio = -869.97

Quarterly (TTM)
Annual
YearPE RatioChange
2024-20.9916.32%
2023-18.04-18.97%
2022-22.27-72.80%
2021-81.8792.71%
2020-42.48-73.30%
2019-159.1025.41%
2018-126.87-64.52%
2017-357.57-58.90%
2016-869.9749.80%
2015-580.77-54.81%

Shanghai Junshi Biosciences Co., Ltd. (1877.HK) Average PE Ratio

How has 1877.HK PE Ratio performed in the past?

The current PE Ratio of Shanghai Junshi Biosciences Co., Ltd. (1877.HK) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-20.43

5-year avg

-37.13

10-year avg

-227.99

Shanghai Junshi Biosciences Co., Ltd. (1877.HK) PE Ratio vs. Peers

How is 1877.HK’s PE Ratio compared to its peers?

Shanghai Junshi Biosciences Co., Ltd.’s PE Ratio is greater than Innovent Biologics, Inc. (-1241.83), greater than BeiGene, Ltd. (-121.80), greater than Akeso, Inc. (-143.32), less than WuXi AppTec Co., Ltd. (16.93), greater than CStone Pharmaceuticals (-53.01),

CompanyPE RatioMarket cap
-1241.83$127.34B
-121.80$221.98B
-143.32$84.31B
16.93$206.80B
-53.01$5.62B

Build a custom stock screener for Shanghai Junshi Biosciences Co., Ltd. (1877.HK) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Shanghai Junshi Biosciences Co., Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Shanghai Junshi Biosciences Co., Ltd. (1877.HK) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Shanghai Junshi Biosciences Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Shanghai Junshi Biosciences Co., Ltd.'s PE Ratio?

How is the PE Ratio calculated for Shanghai Junshi Biosciences Co., Ltd. (1877.HK)?

What is the highest PE Ratio for Shanghai Junshi Biosciences Co., Ltd. (1877.HK)?

What is the 3-year average PE Ratio for Shanghai Junshi Biosciences Co., Ltd. (1877.HK)?

What is the 5-year average PE Ratio for Shanghai Junshi Biosciences Co., Ltd. (1877.HK)?

How does the current PE Ratio for Shanghai Junshi Biosciences Co., Ltd. (1877.HK) compare to its historical average?